Fitzsimons Innovation Community Sees Record Momentum and Breakthroughs

Fitzsimons Innovation Community recently released its Second Annual Innovation Report, Discoveries Meet Momentum, focusing on the Community momentum that allows innovators to take their discoveries and projects from idea to market.

Inaugural recipient of CBSA’s Building Momentum Award. Fitzsimons Innovation Community makes investments that advance Colorado’s life sciences community and better position the entire ecosystem for growth. Expansion and growth are just part of the story. The Fitzsimons Innovation Community advantage is in supporting people, fostering connections, and creating an environment that helps spark discoveries.

Read More

A leading campus for health innovation, Fitzsimons Innovation Community is home to life sciences

companies of all sizes taking their research to the next level to cure diseases, save lives, and improve care. From pharmaceuticals to molecular biology to medical devices, Community members watch their discoveries build momentum within the customized buildings and amenity-filled campus. More than 80 visionary organizations and more than 800 jobs contributed to impressive developments for the Community.

The report explores:

CBSA President and CEO Elyse Blazevich contributed data-driven insights on why companies choose Colorado to start, grow, or relocate.

Colorado is becoming a top hub in the country for life sciences enterprise, currently ranking 8th in North America. With the highest concentration of bioengineering and biomedical talent in the country, more than 720 companies working on life-saving breakthroughs, and almost 35,000 jobs created, Colorado is a destination for innovation, specialized lab space, and raising the investment capital—more than $4 billion over the past two years—to cover all of the above. Fitzsimons Innovation Community is proud to be right in the thick of it.

The Innovation Report includes perspectives and profiles from leaders and health innovators:

AC-REP (Adams County REP)

CBRE

Ceria Therapeutics

City of Aurora

Colorado BioScience Association

CU Anschutz Medical Campus

CU Innovations

EnteroTrack

Exxel Pharma

Foresight Diagnostics

GelSana Therapeutics

HepQuant

InVitria

Metro Denver EDC

Peak Diagnostic Partners

PhosphoSolutions

RheumaGen

UCHealth

Validus Cellular Therapeutics

Vona Oncology

Categories: CBSA News